Travel Award Descriptions
The Stephen G. Holtzman Travel Award for Preclinical Investigators was established by family & friends of Dr. Holtzman to honor his memory in tribute to his long-time service and dedication to the College on Problems of Drug Dependence. This award is given annually or biannually to either a predoctoral student or postdoctoral trainee involved in preclinical research related to substance abuse and dependence.
-
- Qualified applicants are those with excellence in research, but who have not yet received NIH support, or who have obtained research project funding but remain unfunded for travel to the CPDD meeting.
- Predoctoral students must be enrolled in a program working towards a terminal degree.
- Postdoctoral trainees are scientists who are not more than 5 years beyond their doctorate (Ph.D.) or residency (M.D., D.V.M., etc.) as of the start of the Annual Meeting.
- S. citizenship is not a requirement.
- Individuals who have previously received this travel award are not eligible to apply.
Each Award Will Include:
-
- Complimentary registration
- $1000 for travel expenses
CPDD will award competitive travel fellowships to early career investigators (pre-doctoral students enrolled in Ph.D. training programs and post-doctoral scientists within 5 years of terminal degree) or students enrolled in a M.D. program to attend the Annual Scientific Meeting of CPDD.
Eligibility:
- Postdoctoral Awards are available to scientists who are not more than five years beyond their doctorate (Ph.D.) or residency (M.D., D.V.M., etc.).
- Predoctoral Awards are available for individuals in Ph.D. or M.D. programs at institutions with little or no NIH support.
- S. citizens, permanent residents and foreign scientists are eligible to apply.
- Predoctoral students that will be supported by NIDA/NIH training grants or individuals with Predoctoral National Research Service Awards (F31) at the time of the meeting are not eligible for Predoctoral Awards.
- Prior recipients of the CPDD Travel Award for Early Career Investigators (either predoctoral or postdoctoral) are not eligible to reapply.
- Up to a maximum of $1500 for travel expenses and/or registration
- Invitation to an Annual Meeting luncheon for all CPDD Early Career Investigator Awardees for the past 4 years.
The National Institute on Drug Abuse (NIDA) and the College on Problems of Drug Dependence (CPDD) support an International Travel Award for up to two substance abuse researchers from low-income, lower-middle-income, or upper middle-income countries (as defined by the World Bank) to participate in the CPDD Annual Scientific Meeting, and associated research training activities.
Eligibility:
-
-
- Be a substance abuse researcher from a low-income, lower-middle-income, or upper middle-income country who completed his or her doctoral degree or residency no more than 10 years ago.
- Conduct research on any aspect of substance use and substance use disorders.
- Have not received travel support from NIDA or CPDD between July 1 of the previous year and June 1 of the award year.
- Have not previously received the WHO/NIDA/CPDD International Traveling Fellowship or the CPDD International Travel Award in any prior year.
- Live and work outside the United States at the time of application and travel.
- Provide an eligible abstract submitted for CPDD
-
-
-
-
- Up to a maximum of $2,500 for travel expenses (Registration confirmation can be submitted as part of the travel stipend.)
- Complimentary registration to the CPDD meeting for the 2 consecutive years following the award year.
-
-
The National Institute on Drug Abuse (NIDA) anticipates supporting approximately 20 early career investigators to attend the Annual Scientific Meeting of CPDD with the NIDA Director’s Travel Award program. The purpose of the award is to help defray the cost of attending CPDD for promising young scientists supported by NIDA training or career development grants. Awardees will receive free registration in the NIDA Grant-Writing/Career Workshop held on the first day of the meeting (before the opening reception).
Eligibility
-
-
- Must be a NIDA-supported NRSA fellow, NRSA trainee, Diversity Supplement recipient or Mentored Career Development Award PI.
- Awardees must attend the NIDA Grant-Writing/Career Workshop, held in conjunction with the CPDD Meeting. Selection for this travel award will automatically enroll you in this workshop.
- Preference will be given to junior investigators presenting at the CPDD conference, and to those who have not previously received this award.
-
CPDD gives an award for scientists from low-, lower middle-, and upper middle-income countries who present their research at the Joint NIDA International Forum/CPDD Workshop International Research Poster Session.
-
Eligibility:
All eligible poster presenters will be considered for the award if:
- They are citizens of a low-, lower middle-, or upper middle-income country as defined by the World Bank.
- The research was conducted in their home country or another low-, lower middle-, or upper middle-income country.
- They are present during the entire NIDA International Forum/CPDD International Research Poster Session Workshop.
-
*An application is not necessary.
About/Background:
MySafeRx Inc. is a nonprofit organization established to advance scientific research on the development, implementation, and dissemination of technological solutions for addiction treatment and medication adherence.
Technology-based interventions (e.g., digital therapeutics, mobile health platforms, and real-time monitoring systems) represent an expanding area of scientific inquiry in addiction research. Rigorous study of these approaches builds the clinical evidence base and identifies priorities for future research. This work also evaluates how technological innovations may improve patient–provider communication, enhance data quality, and enable more timely interventions.
By investing in the science that generates these solutions, MySafeRx Inc. seeks to advance knowledge that improves clinical outcomes and strengthens the healthcare system’s ability to respond to the complex challenges of addiction with agility and precision. To further this mission, MySafeRx Inc. is proud to support travel to the CPDD Annual Meeting for scientists conducting technology-based interventions for both addiction treatment and medication adherence research.
Affiliation: The applicant must be an academic scientist affiliated with a university or college within the United States and must conduct the majority of their research activities at the affiliated institution.
Presentation Requirements:
1. The applicant must have submitted a scientific abstract to deliver a presentation, either in poster format or as an oral presentation, at the annual College on Problems of Drug Dependence scientific conference.
2. The presentation must directly address scientific research conducted by the applicant related to the development, implementation, or dissemination of technological interventions for addiction treatment and medication adherence.
3. Preference will be given to support projects or applicants whose career focuses on technology-based interventions for both addiction treatment and medication adherence.
Funding Status: The applicant must not currently be a recipient of funding under an NIH T32 grant.
Previous Awards: The applicant must not have previously received the Technology-Based Treatments for Addiction Travel Award in any prior year.
Career Stage: The applicant must qualify as an early-career scientist, defined as being either (1) a current terminal degree graduate student or (2) within ten (10) years of the completion of their Ph.D. or terminal clinical degree (e.g., MD, PsyD)
Awardee will be granted $2,000.
The MySafeRx Inc. 501(c)(3) tax exempt purpose is to support the development, implementation, and dissemination of technological solutions for addiction treatment and medication adherence.